Signaling Pathways for UV-Induced Melanogenic Response

紫外线诱导的黑色素生成反应的信号通路

基本信息

  • 批准号:
    7902757
  • 负责人:
  • 金额:
    $ 9.85万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-08-15 至 2010-08-14
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This competing renewal application aims at investigating the hypothesis that exposure of human melanocytes to ultraviolet radiation (UV) and/or the physiological agonist 1-melanocyte stimulating hormone (1-MSH) or antagonist agouti signaling protein (ASIP) modulates the expression of the melanocortin 1 receptor (MC1R) gene, and regulates the activation of the receptor by affecting its desensitization, internalization and resensitization. The MC1R is a Gs protein-coupled receptor with seven transmembrane domains that is expressed on human melanocytes. Activation of this receptor by its agonists 1-MSH or ACTH stimulates cAMP formation and the synthesis of the brown-black eumelanin, which confers cutaneous photoprotection. We have shown that activation of the MC1R is pivotal for the UV-induced tanning response, and importantly, reduces the extent of UV-induced DNA damage by enhancing nucleotide excision repair and counteracting oxidative stress in human melanocytes. These effects explain why loss-of-function alleles of the MC1R are associated with increased risk for melanoma. We are proposing that MC1R expression and function are regulated at different levels in response to UV, its physiological agonists and antagonist. To investigate the above stated hypothesis, we propose the following three Specific Aims. First, we will investigate the regulation of MC1R gene expression and receptor trafficking by real time RT-PCR, Western blotting, and immunostaining. Second, we will determine the activation of the MC1R, by quantitating the number of membrane receptors/melanocyte, its agonist-induced desensitization, internalization, and resensitization. Third, we will define the roles of G protein receptor kinases (GRKs) and 2-arrestins in MC1R surface expression and sequestration. The significance of the proposed studies lies in the critical role of the MC1R and melanocortins in the UV responses of human melanocytes, and in filling the gap in the existing knowledge about regulation of this receptor in the physiologically-relevant cell, the epidermal melanocyte. Given that the MC1R is a melanoma susceptibility gene and an important determinant of the UV-induced tanning response, elucidating the regulation of MC1R expression and activation will lead to new strategies to prevent melanoma and other types of skin cancer by increasing the activity of the MC1R and optimizing the photoprotective capacity of the melanocyte, particularly in high risk individuals. PUBLIC HEALTH RELEVANCE The outcome of this grant application is expected to lead to new strategies for prevention of melanoma, the deadliest form of skin cancer, and of non-melanoma skin cancers. These strategies will be based on modulating the activity of the melanocortin 1 receptor by mechanisms that will be elucidated during the course of this grant proposal. The incidence of melanoma in the U.S. and Eastern countries continues to rise with no effective treatment for advanced disease; hence the relevance of this project for public health.
描述(申请人提供):该竞争性更新申请旨在研究以下假设:人黑素细胞暴露于紫外线辐射(UV)和/或生理激动剂1-黑素细胞刺激激素(1-MSH)或拮抗剂促黑素细胞激素信号传导蛋白(ASIP)调节黑皮质素1受体(MC 1 R)基因的表达,并通过影响其脱敏来调节受体的激活,内化和再敏感化。MC 1 R是一种具有7个跨膜结构域的Gs蛋白偶联受体,在人黑素细胞上表达。通过其激动剂1-MSH或ACTH激活该受体,刺激cAMP形成和棕黑色真黑素的合成,其赋予皮肤光保护。我们已经表明,MC 1 R的激活是紫外线诱导的晒黑反应的关键,并且重要的是,通过增强核苷酸切除修复和抵消人黑素细胞中的氧化应激来降低紫外线诱导的DNA损伤的程度。这些效应解释了为什么MC 1 R的功能丧失等位基因与黑色素瘤风险增加相关。我们提出,MC 1 R的表达和功能调节在不同的水平上响应UV,其生理激动剂和拮抗剂。为了研究上述假设,我们提出了以下三个具体目标。首先,我们将通过真实的时间RT-PCR、蛋白质印迹和免疫染色来研究MC 1 R基因表达和受体运输的调控。其次,我们将通过定量膜受体/黑素细胞的数量、其激动剂诱导的脱敏、内化和再敏化来确定MC 1 R的激活。第三,我们将确定G蛋白受体激酶(GRKs)和2-arrestins在MC 1 R表面表达和隔离的作用。所提出的研究的意义在于MC 1 R和黑皮质素在人黑素细胞的UV响应中的关键作用,以及填补了关于生理相关细胞(表皮黑素细胞)中该受体的调节的现有知识中的差距。鉴于MC 1 R是黑色素瘤易感基因和UV诱导的晒黑反应的重要决定因素,阐明MC 1 R表达和活化的调节将导致通过增加MC 1 R的活性和优化黑色素细胞的光保护能力来预防黑色素瘤和其他类型的皮肤癌的新策略,特别是在高风险个体中。 这项拨款申请的结果预计将导致预防黑色素瘤(最致命的皮肤癌形式)和非黑色素瘤皮肤癌的新策略。这些策略将基于调节黑皮质素1受体的活性,其机制将在本拨款申请过程中阐明。黑色素瘤在美国和东方国家的发病率持续上升,没有有效的治疗晚期疾病;因此,该项目与公共卫生的相关性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ZALFA ABDEL-MALEK其他文献

ZALFA ABDEL-MALEK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ZALFA ABDEL-MALEK', 18)}}的其他基金

Vitiligo topical treatment applying a potent, highly selective MC1R agonist
使用强效、高选择性 MC1R 激动剂进行白癜风局部治疗
  • 批准号:
    10759768
  • 财政年份:
    2023
  • 资助金额:
    $ 9.85万
  • 项目类别:
Targeting the Melanocortin 1 Receptor by Selective Small Analogs of α-Melanocortin for Melanoma Prevention
通过选择性α-黑皮质素小类似物靶向黑皮质素 1 受体预防黑色素瘤
  • 批准号:
    10474302
  • 财政年份:
    2018
  • 资助金额:
    $ 9.85万
  • 项目类别:
Targeting the Melanocortin 1 Receptor by Selective Small Analogs of α-Melanocortin for Melanoma Prevention
通过选择性α-黑皮质素小类似物靶向黑皮质素 1 受体预防黑色素瘤
  • 批准号:
    10265379
  • 财政年份:
    2018
  • 资助金额:
    $ 9.85万
  • 项目类别:
Targeting the Melanocortin 1 Receptor by Selective Small Analogs of α-Melanocortin for Melanoma Prevention
通过选择性α-黑皮质素小类似物靶向黑皮质素 1 受体预防黑色素瘤
  • 批准号:
    9898307
  • 财政年份:
    2018
  • 资助金额:
    $ 9.85万
  • 项目类别:
Melanoma prevention by MC1R selective small peptide analogs of alpha MSH
通过 MC1R 选择性 α MSH 小肽类似物预防黑色素瘤
  • 批准号:
    9105353
  • 财政年份:
    2015
  • 资助金额:
    $ 9.85万
  • 项目类别:
Melanoma prevention by MC1R selective small peptide analogs of alpha MSH
通过 MC1R 选择性 α MSH 小肽类似物预防黑色素瘤
  • 批准号:
    8958319
  • 财政年份:
    2015
  • 资助金额:
    $ 9.85万
  • 项目类别:
How p16 and MC1R mutations synergistically exacerbate melanoma risk.
p16 和 MC1R 突变如何协同加剧黑色素瘤风险。
  • 批准号:
    8652005
  • 财政年份:
    2014
  • 资助金额:
    $ 9.85万
  • 项目类别:
Impact of MC1R Functional Variants on the DNA Damage Response of Human Melanocyte
MC1R 功能变异对人黑素细胞 DNA 损伤反应的影响
  • 批准号:
    7730250
  • 财政年份:
    2009
  • 资助金额:
    $ 9.85万
  • 项目类别:
Impact of MC1R Functional Variants on the DNA Damage Response of Human Melanocyte
MC1R 功能变异对人黑素细胞 DNA 损伤反应的影响
  • 批准号:
    8462256
  • 财政年份:
    2009
  • 资助金额:
    $ 9.85万
  • 项目类别:
Impact of MC1R Functional Variants on the DNA Damage Response of Human Melanocyte
MC1R 功能变异对人黑素细胞 DNA 损伤反应的影响
  • 批准号:
    8274543
  • 财政年份:
    2009
  • 资助金额:
    $ 9.85万
  • 项目类别:

相似海外基金

Neuroendocrine regulation of energy metabolism: role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the thermoregulatory cascade
能量代谢的神经内分泌调节:垂体腺苷酸环化酶激活多肽(PACAP)在温度调节级联中的作用
  • 批准号:
    RGPIN-2021-04040
  • 财政年份:
    2022
  • 资助金额:
    $ 9.85万
  • 项目类别:
    Discovery Grants Program - Individual
Controlled Release of Pituitary Adenylate Cyclase Activating Polypeptide from a Hydrogel-Nanoparticle Delivery Vehicle for Applications in the Central Nervous System
从水凝胶-纳米粒子递送载体中控制释放垂体腺苷酸环化酶激活多肽,用于中枢神经系统的应用
  • 批准号:
    547124-2020
  • 财政年份:
    2022
  • 资助金额:
    $ 9.85万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Controlled Release of Pituitary Adenylate Cyclase Activating Polypeptide from a Hydrogel-Nanoparticle Delivery Vehicle for Applications in the Central Nervous System
从水凝胶-纳米粒子递送载体中控制释放垂体腺苷酸环化酶激活多肽,用于中枢神经系统的应用
  • 批准号:
    547124-2020
  • 财政年份:
    2021
  • 资助金额:
    $ 9.85万
  • 项目类别:
    Postgraduate Scholarships - Doctoral
Neuroendocrine regulation of energy metabolism: role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the thermoregulatory cascade
能量代谢的神经内分泌调节:垂体腺苷酸环化酶激活多肽(PACAP)在温度调节级联中的作用
  • 批准号:
    RGPIN-2021-04040
  • 财政年份:
    2021
  • 资助金额:
    $ 9.85万
  • 项目类别:
    Discovery Grants Program - Individual
The Molecular Mechanism of the Secretion of the Bacterial Toxin Adenylate Cyclase
细菌毒素腺苷酸环化酶分泌的分子机制
  • 批准号:
    451966
  • 财政年份:
    2021
  • 资助金额:
    $ 9.85万
  • 项目类别:
    Operating Grants
The role of prefrontostriatal Pituitary Adenylate Cyclase Activating Polypeptide in excessive and compulsive ethanol drinking
前额纹状体垂体腺苷酸环化酶激活多肽在过量和强迫性乙醇饮酒中的作用
  • 批准号:
    10455587
  • 财政年份:
    2020
  • 资助金额:
    $ 9.85万
  • 项目类别:
The role of prefrontostriatal Pituitary Adenylate Cyclase Activating Polypeptide in excessive and compulsive ethanol drinking
前额纹状体垂体腺苷酸环化酶激活多肽在过量和强迫性乙醇饮酒中的作用
  • 批准号:
    10261394
  • 财政年份:
    2020
  • 资助金额:
    $ 9.85万
  • 项目类别:
Diagnosis and therapeutic effect of neurally mediated syncope (NMS) using fluctuation of adenylate cyclase activity
利用腺苷酸环化酶活性波动对神经介导性晕厥(NMS)的诊断和治疗效果
  • 批准号:
    20K08498
  • 财政年份:
    2020
  • 资助金额:
    $ 9.85万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Pituitary adenylate cyclase-activating polypeptide 27 in the paraventricular thalamus and its projections: Role in ethanol drinking
室旁丘脑中的垂体腺苷酸环化酶激活多肽 27 及其预测:在乙醇饮用中的作用
  • 批准号:
    10380126
  • 财政年份:
    2020
  • 资助金额:
    $ 9.85万
  • 项目类别:
The role of prefrontostriatal Pituitary Adenylate Cyclase Activating Polypeptide in excessive and compulsive ethanol drinking
前额纹状体垂体腺苷酸环化酶激活多肽在过量和强迫性乙醇饮酒中的作用
  • 批准号:
    10662279
  • 财政年份:
    2020
  • 资助金额:
    $ 9.85万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了